about
Complete regression of human malignant mesothelioma xenografts following local injection of midkine promoter-driven oncolytic adenovirusGene therapy for malignant mesothelioma: beyond the infant years.Deliberately provoking local inflammation drives tumors to become their own protective vaccine site.CD40-activated B cells contribute to mesothelioma tumor regression.
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Gene therapy of mesothelioma.
@ast
Gene therapy of mesothelioma.
@en
type
label
Gene therapy of mesothelioma.
@ast
Gene therapy of mesothelioma.
@en
prefLabel
Gene therapy of mesothelioma.
@ast
Gene therapy of mesothelioma.
@en
P2093
P2860
P1476
Gene therapy of mesothelioma.
@en
P2093
Bruce W S Robinson
Delia J Nelson
Jane Allan
Robbert van der Most
P2860
P304
P356
10.1517/14712598.5.8.1039
P407
P577
2005-08-01T00:00:00Z